6525792
Last Update Posted: 2024-07-29
Recruiting has ended
All Genders accepted | 18 Years + |
62 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic Stroke
Clinical studies applying ozonated autohemotherapy to treat acute cerebrovascular diseases have validated the safety and efficacy of this treatment, as well as explored its mechanism of action.
Eligibility
Relevant conditions:
Acute Ischemic Cerebrovascular Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov